MBA ENTERPRISES LTD
Company number 14718600 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
MBA ENTERPRISES LTD - Analysis Report
Company Number: 14718600
Analysis Date: 2025-07-29 20:23 UTC
Risk Rating: MEDIUM
MBA ENTERPRISES LTD is a micro-entity operating in the medical practice sector with a relatively short operating history since incorporation in March 2023. The company shows positive net assets and no overdue filings, but the balance sheet reveals significant liabilities falling due after one year, which warrants cautious monitoring.Key Concerns:
- Long-term liabilities exceed shareholders’ funds: The company reports £34,065 in creditors due after one year, which is higher than the reported shareholders’ funds of £24,568, indicating potential solvency pressure if long-term obligations cannot be met by future earnings or refinancing.
- Limited operating history and size: Being newly incorporated and classified as a micro-entity with only one employee limits the available financial track record and operational scale, increasing uncertainty about sustainability and resilience to business shocks.
- Concentration of control: One individual, Mr. Laurence Petersen, holds 75-100% ownership and voting rights and is also the sole director, which may present governance and succession risk if there is a lack of independent oversight.
- Positive Indicators:
- Compliance and timely filings: The company’s accounts and confirmation statement are up to date with no overdue returns, indicating good adherence to statutory requirements.
- Positive net current assets: Current assets (£64,313) exceed current liabilities (£27,902), resulting in net current assets of approximately £36,411, suggesting adequate short-term liquidity at the balance sheet date.
- Clear legal structure and registered address: The company is properly registered with a credible London address, which supports operational legitimacy.
- Due Diligence Notes:
- Clarify nature and terms of long-term liabilities: Investigate the composition of the £34,065 creditors due after one year, including repayment schedules and interest obligations, to assess refinancing risk and impact on solvency.
- Review cash flow forecasts and business plan: Given the company’s youth and micro status, understanding the revenue model, client base, and expected cash flows is critical to evaluating future liquidity and operational stability.
- Assess director’s background and governance practices: Given the sole director’s significant control, further inquiry into his professional reputation, experience in the healthcare sector, and any related party transactions is advisable.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.